- Y Diweddaraf sydd Ar Gael (Diwygiedig)
- Pwynt Penodol mewn Amser (12/07/2012)
- Gwreiddiol (a wnaed Fel)
Version Superseded: 14/07/2014
Point in time view as at 12/07/2012.
There are currently no known outstanding effects for the The Quality and Safety of Organs Intended for Transplantation Regulations 2012.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Regulation 5
1. The Authority may on application grant a licence for the purposes of regulation 5.U.K.
2. It shall be a condition of a licence for a procurement activity or a transplantation activity for the licence holder—
(a)to have in place operating procedures for the management of a serious adverse event or a serious adverse reaction;
(b)to rapidly report to the Authority—
(i)relevant and necessary information concerning serious adverse events that may influence the quality and safety of organs and that may be attributed to the testing, characterisation, procurement, preservation, and transport of organs, as well as any serious adverse reaction observed during or after transplantation which may be connected to those activities, and
(ii)the management measures taken with regard to such a serious adverse event or reaction;
(c)to ensure that the healthcare personnel directly involved in the chain from donation to the transplantation or disposal of an organ are—
(i)competent,
(ii)suitably qualified or trained, and
(iii)provided with the training necessary,
to perform their tasks;
(d)to ensure that the data required to ensure the traceability of organs is kept for 30 years from the date of the retrieval of the organ;
(e)to keep information on organ and donor characterisation for a period specified by the Authority in directions given under regulation 11;
(f)to ensure that medical activities are performed under the advice and guidance of a registered medical practitioner; and
(g)to have in place operating procedures demonstrating how the requirements in sub-paragraphs (b) and (d) to (f) shall be complied with.
3. It shall be a condition of a licence for a procurement activity for the licence holder—U.K.
(a)to ensure that procurement material and equipment which could affect the quality and safety of an organ are managed in accordance with relevant European Union, international and national legislation, standards and guidelines on the sterilisation of medical devices; and
(b)to have in place operating procedures demonstrating how the requirements in sub-paragraph (a) shall be complied with.
4. It shall be a condition of a licence for the procurement activity of retrieval of an organ for a licence holder to ensure that—U.K.
(a)the procurement is carried out only after all of the requirements relating to consent and authorisation have been met; and
(b)endeavours are made to follow-up a living donor for the purposes of identifying and managing any event potentially relating to the quality and safety of the donated organ and any serious adverse reaction in the living donor that may result from the donation, and to identify, report to the Authority, and manage any event or reaction.
5. It shall be a condition of a licence for the procurement activity of donor characterisation, and the procurement or transplantation activity of organ characterisation, for the licence holder to ensure—U.K.
(a)that where a donor is deceased, a registered medical practitioner, or a person acting under the supervision of a registered medical practitioner, has endeavoured to obtain information from relatives of the deceased donor or other persons about the donor and has explained to such persons the importance of swift transmission of that information; and
(b)subject to paragraph 7, that donors and organs are characterised before implantation by—
(i)the collection of information specified in part A of the Annex to the Directive, and
(ii)where considered appropriate by a registered medical practitioner, or a person acting under the supervision of a registered medical practitioner, the collection of the information specified in part B of the Annex to the Directive, as amended by amendments that have been adopted and have come into force.
6. It shall be a condition of a licence for the transplantation activity of implantation for the licence holder—U.K.
(a)to ensure that, subject to paragraph 7, the following have been verified before proceeding to implant an organ in a recipient—
(i)identification of the donor,
(ii)the collection of information prescribed in paragraph 5(b), and
(iii)compliance with the conditions in paragraph 8 about the preservation and transportation of shipped organs; and
(b)to have in place operating procedures demonstrating how the requirements in sub-paragraph (a) (i) and (ii) shall be complied with.
7. Where any of the information specified in part A of the Annex to the Directive is not available, it shall be a licensing condition for the transplantation activity of implantation for the licence holder to conduct a risk-benefit analysis to determine whether the expected benefits for the recipient of the organ outweigh the risks posed by the lack of any information.U.K.
8. It shall be a condition of a licence for a procurement activity or a transplantation activity that arrangements to transport an organ are made by the licence holder—U.K.
(a)to maintain the integrity of the organ during transport and that the transport time is suitable to optimise the quality and safety of the organ;
(b)to ensure that, subject to paragraph 9, the shipping containers used for transporting organs are labelled with the following information—
(i)identification of the licence holder responsible for the retrieval of the organ and the place where the retrieval took place, including an address and telephone number for that place,
(ii)identification of the place that an organ will be implanted in a recipient, including its address and telephone number,
(iii)a statement that the package contains an organ, specifying the type of organ and, where applicable, its left or right location and marked “HANDLE WITH CARE”, and
(iv)recommended transport conditions, including instructions for keeping the container at an appropriate temperature and position;
(c)to ensure that the organs transported are accompanied by a report on the organ and donor characterisation; and
(d)to have in place operating procedures demonstrating how the requirements in sub-paragraphs (a) to (c) shall be complied with.
9. The conditions in paragraph 8(b) do not apply where transportation is carried out in the same establishment.U.K.
10. In determining the amounts of any fees to be charged under paragraph 13 (applications under Schedule 3 to the 2004 Act and accompanying fees) of Schedule 3 to the 2004 Act, as applied by regulation 6, the Authority shall have regard to its costs in connection with the consideration of applications for licences under this Schedule.
Regulation 11
1. For the purposes of ensuring consistent compliance with the licensing conditions prescribed in Schedule 1 , the Authority shall give directions under section 23(1) (conduct of licensed activities) of the 2004 Act, as applied by regulation 6, specifying—U.K.
(a)the serious adverse events or serious adverse reactions that must be notified to the Authority, including the time period for such notification;
(b)the data, or type of data, that must be kept to ensure the traceability of organs;
(c)how long information on organ and donor characterisation must be kept for;
(d)the medical activities, or the types of medical activities, that must be performed under the advice and guidance of a registered medical practitioner;
(e)the European Union, international and national legislation and standards on the sterilisation of medical devices which shall be complied with (and the guidelines on the sterilisation of medical devices which shall be taken into account) in respect of procurement material and equipment which could affect the quality and safety of an organ, or the health of the donor or recipient; and
(f)the adequate facilities and equipment that should be used for organ and donor characterisation.
2. For the purpose of ensuring consistent standards in relation to the procurement activity of donor characterisation and the procurement or transplantation activity of organ characterisation, the Authority shall specify in directions given under section 23(1) of the 2004 Act—U.K.
(a)the requirements that apply to laboratories carrying out tests for donor and organ characterisation, to ensure that those tests are carried out by laboratories with suitably qualified, trained and competent personnel and with adequate facilities and equipment; and
(b)the appropriate operating procedures that are to be in place to ensure that information on organ and donor characterisation reaches the person who will implant the organ in a recipient before the quality and safety of the organ is compromised.
Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.
Gwreiddiol (Fel y’i Deddfwyd neu y’i Gwnaed): Mae'r wreiddiol fersiwn y ddeddfwriaeth fel ag yr oedd pan gafodd ei deddfu neu eu gwneud. Ni wnaed unrhyw newidiadau i’r testun.
Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Mae Memoranda Esboniadol yn nodi datganiad byr o ddiben Offeryn Statudol ac yn rhoi gwybodaeth am ei amcan polisi a goblygiadau polisi. Maent yn ceisio gwneud yr Offeryn Statudol yn hygyrch i ddarllenwyr nad oes ganddynt gymhwyster cyfreithiol, ac maent yn cyd-fynd ag unrhyw Offeryn Statudol neu Offeryn Statudol Drafft a gyflwynwyd ger bron y Senedd o Fehefin 2004 ymlaen.
Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:
liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys